Status:

COMPLETED

Patient Activation Through Community Empowerment/Engagement for Diabetes Management (PACE-D)

Lead Sponsor:

National University Health System, Singapore

Collaborating Sponsors:

National University Hospital, Singapore

National University of Singapore

Conditions:

Diabetes Mellitus

Chronic Disease

Eligibility:

All Genders

21-99 years

Phase:

NA

Brief Summary

The study is a non-randomised controlled trial involving an intervention group and a control group. It aims to evaluate the effects of a patient engagement and empowerment model of collaborative care ...

Detailed Description

The investigators will conduct a prospective study on existing patients with diabetes who are on follow-up with their teamlets at Pioneer (PIO), Jurong (JUR), Bukit Batok (BBK) and Choa Chu Kang (CCK)...

Eligibility Criteria

Inclusion

  • On follow up with an existing teamlet pre-assigned to participate in the study
  • Adults with diabetes mellitus
  • Age 21 years and above
  • Ability to provide informed consent
  • Ability to communicate in the language(s) which the physician is confident to carry out the care and support planning consult in English, Malay or Chinese
  • Ability to read and comprehend the Diabetes Results Letter on their own OR has family members who are able to assist to that

Exclusion

  • Doctors, Care Managers and Care Coordinators involved in the care and support planning process
  • Age 21 years and above
  • Ability to provide informed consent

Key Trial Info

Start Date :

March 25 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2022

Estimated Enrollment :

1620 Patients enrolled

Trial Details

Trial ID

NCT04288362

Start Date

March 25 2019

End Date

March 31 2022

Last Update

April 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National University Polyclinics

Singapore, Singapore, 609606